Chongqing Peg-bio Biopharm Co., Ltd.

This early-stage trial tested a new drug called PN20 in 24 adults with lymphoma or solid tumors who were getting chemotherapy. The goal was to see if a single injection before chemo could safely prevent a drop in platelets, which can cause bleeding. Researchers checked safety and…

This early-stage study tested the safety of a new drug called FT1 in 60 healthy adults aged 18 to 45. Participants received either FT1 or a placebo injection. The goal was to see if FT1 is safe and how the body processes it.